mifepristone has been researched along with Atherogenesis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inaba, N; Kurachi, H; Mochizuki, Y; Ohmichi, M; Oishi, A; Takahashi, K | 1 |
Blaxall, BC; Dhawan, L; Liu, B; Taubman, MB | 1 |
2 other study(ies) available for mifepristone and Atherogenesis
Article | Year |
---|---|
Role of glucocorticoid receptor in the inhibitory effect of medroxyprogesterone acetate on the estrogen-induced endothelial nitric oxide synthase phosphorylation in human umbilical vein endothelial cells.
Topics: Atherosclerosis; Cells, Cultured; Contraceptive Agents, Female; Endothelial Cells; Estrogens; Hormone Antagonists; Humans; Medroxyprogesterone Acetate; Mifepristone; Nitric Oxide Synthase Type III; Phosphorylation; Receptors, Glucocorticoid; Risk Factors; RNA, Small Interfering; Umbilical Veins | 2011 |
A novel role for the glucocorticoid receptor in the regulation of monocyte chemoattractant protein-1 mRNA stability.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Cell-Free System; Cells, Cultured; Chemokine CCL2; Dexamethasone; Hormone Antagonists; Humans; Inflammation; Male; Mifepristone; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; RNA Stability | 2007 |